case_images: PMC8265029_01
case_images: Angiotensin II, C-reactive protein, and interleukin-6 levels over time in case 1 (a), case 2 (b), case 3 (c), and case 4 (d).
case_images: JRAAS2021-9951540.001.jpg
case_images: PMC8265029_04_JRAAS2021-9951540.001.jpg
case_images: fig1
case_images: II levels increased from 552 pg/mL to 840 pg/mL at 16 days after admission. In contrast, IL-6 levels decreased from 12.86 pg/mL to 0.17 pg/mL, and CRP levels decreased from 18.05 mg/dL to 3.78 mg/dL (Figure 1(d)).
case_images: PMC8265029_02
case_images: Angiotensin II, C-reactive protein, and interleukin-6 levels over time in case 1 (a), case 2 (b), case 3 (c), and case 4 (d).
case_images: JRAAS2021-9951540.001.jpg
case_images: PMC8265029_04_JRAAS2021-9951540.001.jpg
case_images: fig1
case_images: II levels increased from 552 pg/mL to 840 pg/mL at 16 days after admission. In contrast, IL-6 levels decreased from 12.86 pg/mL to 0.17 pg/mL, and CRP levels decreased from 18.05 mg/dL to 3.78 mg/dL (Figure 1(d)).
case_images: PMC8265029_03
case_images: Angiotensin II, C-reactive protein, and interleukin-6 levels over time in case 1 (a), case 2 (b), case 3 (c), and case 4 (d).
case_images: JRAAS2021-9951540.001.jpg
case_images: PMC8265029_04_JRAAS2021-9951540.001.jpg
case_images: fig1
case_images: II levels increased from 552 pg/mL to 840 pg/mL at 16 days after admission. In contrast, IL-6 levels decreased from 12.86 pg/mL to 0.17 pg/mL, and CRP levels decreased from 18.05 mg/dL to 3.78 mg/dL (Figure 1(d)).
case_images: PMC8265029_04
case_images: Angiotensin II, C-reactive protein, and interleukin-6 levels over time in case 1 (a), case 2 (b), case 3 (c), and case 4 (d).
case_images: JRAAS2021-9951540.001.jpg
case_images: PMC8265029_04_JRAAS2021-9951540.001.jpg
case_images: fig1
case_images: II levels increased from 552 pg/mL to 840 pg/mL at 16 days after admission. In contrast, IL-6 levels decreased from 12.86 pg/mL to 0.17 pg/mL, and CRP levels decreased from 18.05 mg/dL to 3.78 mg/dL (Figure 1(d)).